FDA approves new DNA-based test to determine blood compatibility
date:Oct 12, 2018
lternative to testing blood with antisera, said Peter Marks, M.D., Ph.D., director of the FDAs Center for Biologics Evaluation and Research. We know that DNA testing holds great promise to provide more informative, accurate and cost-effective methods that can enhance patient care.

Human blood can be classified into different groups based on the antigens on the surfaces of red blood cells. In addition to the ABO blood group antigens, the presence or absence of other specific blood group antigen
2/5 next page prev page home page last page
go back |  refresh |  WAP home |  Web page version  | login
07/10 18:53